ExcepGen Emerges From Stealth with New Funding for its Nucleic Acid Therapeutics Platform

SAN FRANCISCO, Aug. 24, 2023 /PRNewswire/ — ExcepGen, a genetic medicine startup, emerged from stealth after the successful completion of its newest funding round. The most recent $4 million round, which brings the company’s total seed funding to $14 million, was led by RA Capital…

Click here to view original post


ADVERTISEMENT — Advertise With Biotech Networks